| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |